Publications of Yvonne Genzel

Zinnecker, T. M., Badri, N., Araujo, D., Hinkelmann, A., Thiele, K., Reichl, U., & Genzel, Y.A quest for the best influenza producing clonal MDCK cell line: intensifying by design of experiments, ambr15 and bench-top bioreactor cultivationsPresented at: World Biopharm Forum 2023 - Democratisation of biotherapies: new manufacturing modalities and intensificationsOxford (United Kingdom), June 21, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition):Upstream Process Development - From Master Seed to ProductionPresented at: ESACT Course 2022Llafranc (Spain), October 2, 2022.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition):Upstream Process IntensificationPresented at: ESACT Course 2022Llafranc (Spain), October 2, 2022.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise.Presented at: ESACT Course 2022Llafranc (Spain), October 2, 2022.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition): Exercise on vaccine designPresented at: ESACT Course 2022Llafranc (Spain), October 2, 2022.

Göbel, S., Pelz, L., Behrendt, I., Prömmel, M., Altomonte, J., Anderlei, T., Bürgin, T., Genzel, Y., & Reichl, U.Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionPresented at: Single-Use Technologies V: Building the FutureMarseille, France, March 20, 2022.

Gränicher, G., Göbel, S., Marichal-Gallardo, P., Jordan, I., Sandig, V., Genzel, Y., & Reichl, U.Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapyPresented at: Value through intensified bioprocessing IIOxford, United Kingdom, June 22, 2022.

Gränicher, G., Göbel, S., Marichal-Gallardo, P., Jordan, I., Sandig, V., Genzel, Y., & Reichl, U.Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapyPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Hein, M., Chawla, A., Arora , P., Cattaneo, M., Winkler, M., Pöhlmann, S., Schughart, K., Genzel, Y., Kupke, S. Y., & Reichl, U.Production of influenza A virus defective interfering particles in a high cell density perfusion cultivation with continuous virus harvestingPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Hein, M., Dogra, T., Arora , P., Rand , U., Genzel, Y., Cattaneo, M., Winkler, M., Cicin-Sain, L., Bruder, D., Schughart, K., Pöhlmann, S., Kupke, S. Y., & Reichl, U.Influenza A Virus-Derived Defective Interfering Particles for Antiviral TreatmentPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Pelz, L., Rüdiger, D., Dogra, T., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral CandidatesPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Pelz, L., Rüdiger, D., Dogra, T., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidatesPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Zinnecker, T. M., Behrendt, I., Lau , M., Hinkelmann, A., Thiele, K., Badri, N., Araujo, D., Genzel, Y., & Reichl, U.Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactorsPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition):Cells, Upstream Processing and Process IntensificationPresented at: ESACT Course 2021Virtual Meeting, September 27, 2021.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Overview on COVID-19 candidate vaccinesPresented at: ESACT Course 2021Virtual Meeting, September 27, 2021.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 antigen design options and vaccination platformsPresented at: ESACT Course 2021Virtual Meeting, September 27, 2021.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 vaccine manufacturing platforms and cost-effectivenessPresented at: ESACT Course 2021Virtual Meeting, September 27, 2021.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 vaccines immunology and protectionPresented at: ESACT Course 2021Virtual Meeting, September 27, 2021.

Genzel, Y.Process intensification for virus production: stirred or shaken perfusion leads to very high titresPresented at: World Vaccine Congress WashingtonVirtual Meeting, September 28, 2020.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition):Cells, Upstream Processing and Process IntensificationPresented at: ESACT Course 2020Virtual Meeting, September 28, 2020.